169 related articles for article (PubMed ID: 1434646)
1. Biological monitoring of cancer chemoprevention.
Pillai R; Garewal HS; Wood S; Watson RR
J Surg Oncol; 1992 Nov; 51(3):195-202. PubMed ID: 1434646
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of oral cancer: the need for effective biological monitoring.
Pillai MR; Ravi D; Nair MK
Singapore Dent J; 1997 Aug; 22(1):6-12. PubMed ID: 10597170
[TBL] [Abstract][Full Text] [Related]
3. Intermediate biomarkers of precancer and their application in chemoprevention.
Kelloff GJ; Malone WF; Boone CW; Steele VE; Doody LA
J Cell Biochem Suppl; 1992; 16G():15-21. PubMed ID: 1469895
[TBL] [Abstract][Full Text] [Related]
4. Intermediate Biomarkers of Precancer and their Application in Chemoprevention. Workshop. Keystone, Colorado, October 3-7, 1991.
J Cell Biochem Suppl; 1992; 16G():1-196. PubMed ID: 1361588
[No Abstract] [Full Text] [Related]
5. The study of markers of biological effect in cancer prevention research trials.
Greenwald P; Witkin KM; Malone WF; Byar DP; Freedman LS; Stern HR
Int J Cancer; 1992 Sep; 52(2):189-96. PubMed ID: 1521908
[TBL] [Abstract][Full Text] [Related]
6. Risk biomarkers and current strategies for cancer chemoprevention.
Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
[TBL] [Abstract][Full Text] [Related]
7. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
Greenwald P
J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
[TBL] [Abstract][Full Text] [Related]
8. Surrogate endpoint biomarkers and their modulation in cervical chemoprevention trials.
Follen M; Schottenfeld D
Cancer; 2001 May; 91(9):1758-76. PubMed ID: 11335902
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers and surrogacy: relevance to chemoprevention.
Kensler TW; Davidson NE; Groopman JD; Muñoz A
IARC Sci Publ; 2001; 154():27-47. PubMed ID: 11220666
[TBL] [Abstract][Full Text] [Related]
10. Surrogate end-point biomarkers in chemopreventive drug development.
Kelloff GJ; Sigman CC; Hawk ET; Johnson KM; Crowell JA; Guyton KZ
IARC Sci Publ; 2001; 154():13-26. PubMed ID: 11220652
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of prostate cancer: concepts and strategies.
Kelloff GJ; Lieberman R; Steele VE; Boone CW; Lubet RA; Kopelovitch L; Malone WA; Crowell JA; Sigman CC
Eur Urol; 1999; 35(5-6):342-50. PubMed ID: 10325487
[TBL] [Abstract][Full Text] [Related]
12. Surrogate endpoint biomarkers for phase II cancer chemoprevention trials.
Kelloff GJ; Boone CW; Crowell JA; Steele VE; Lubet R; Doody LA
J Cell Biochem Suppl; 1994; 19():1-9. PubMed ID: 7823579
[TBL] [Abstract][Full Text] [Related]
13. Morphological intermediate biomarkers in cancer chemoprevention.
Risio M
Eur J Cancer Prev; 1994 Jul; 3(4):366-8. PubMed ID: 7950894
[No Abstract] [Full Text] [Related]
14. Chemoprevention of cancer: review of the literature.
Swan DK; Ford B
Oncol Nurs Forum; 1997 May; 24(4):719-27. PubMed ID: 9159786
[TBL] [Abstract][Full Text] [Related]
15. Strategies for identification and clinical evaluation of promising chemopreventive agents.
Kelloff GJ; Hawk ET; Crowell JA; Boone CW; Nayfield SG; Perloff M; Steele VE; Lubet RA
Oncology (Williston Park); 1996 Oct; 10(10):1471-84; discussion 1484-8. PubMed ID: 8905841
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers in cancer chemoprevention. Workshop report.
IARC Sci Publ; 2001; 154():1-12. PubMed ID: 11220649
[No Abstract] [Full Text] [Related]
17. Molecular medicine and the development of cancer chemopreventive agents.
Izzotti A
Ann N Y Acad Sci; 2012 Jul; 1259():26-32. PubMed ID: 22758633
[TBL] [Abstract][Full Text] [Related]
18. Molecular and clinical risk markers in colon cancer trials.
Hill MJ
Eur J Cancer; 2000 Jun; 36(10):1288-91. PubMed ID: 10882868
[TBL] [Abstract][Full Text] [Related]
19. Prostatic intraepithelial neoplasia (PIN) and other prostatic lesions as risk factors and surrogate endpoints for cancer chemoprevention trials.
Bostwick DG; Aquilina JW
J Cell Biochem Suppl; 1996; 25():156-64. PubMed ID: 9027613
[TBL] [Abstract][Full Text] [Related]
20. Cancer chemoprevention: progress and promise.
Kelloff GJ; Sigman CC; Greenwald P
Eur J Cancer; 1999 Dec; 35(14):2031-8. PubMed ID: 10711244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
